ArticlePLoS biology2026

Disrupting CD22-cis-ligand interactions ameliorates type 1 diabetes and graft rejection by expanding regulatory B cells.

Wang Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.